Status:
RECRUITING
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
Lead Sponsor:
ROM Technologies, INC
Conditions:
Myocardial Infarction
Percutaneous Transluminal Coronary Angioplasty
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to evaluate feasibility, efficacy, and adherence of home-based cardiac rehabilitation with the integration of telemedicine. Several components will be assessed such as quality...
Detailed Description
The focus of this study is to determine the feasibility, efficacy, and adherence of home-based cardiac rehabilitation with the integration of telemedicine. The study consists of an initial review, reh...
Eligibility Criteria
Inclusion
- Over the age of 18
- NYHA Functional Class I, II,
- Recent (within 60 days) status post coronary artery revascularization for atherosclerotic coronary artery disease (coronary artery bypass grafting or percutaneous coronary revascularization with stent implantation)
- Candidate for traditional center-based cardiac rehabilitation
Exclusion
- Under the age of 18
- Adults lacking capacity to consent.
- NYHA Functional Class III, IV
- Acute coronary syndrome
- Systolic heart failure (LV EF \<40%)
- Status post cardiac surgery for structural heart disease or heart transplant
- Percutaneous coronary angioplasty
- Adults lacking capacity to consent.
- Pregnant women
Key Trial Info
Start Date :
June 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05972070
Start Date
June 1 2023
End Date
December 31 2025
Last Update
July 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ROMTech
Brookfield, Connecticut, United States, 06804